Profile data is unavailable for this security.
About the company
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. Its segments include Laboratory Solutions and Bioscience Production. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, and biological safety cabinets. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
- Revenue in USD (TTM)6.83bn
- Net income in USD360.20m
- Incorporated2016
- Employees14.50k
- LocationAvantor IncBuilding One100 W Matsonford Rd Ste 200RADNOR 19087United StatesUSA
- Phone+1 (610) 386-1700
- Fax+1 (302) 636-5454
- Websitehttps://www.avantorsciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bruker Corp | 3.12bn | 352.10m | 10.11bn | 9.71k | 27.80 | 5.65 | 20.41 | 3.24 | 2.40 | 2.40 | 21.24 | 11.82 | 0.6393 | 1.47 | 5.90 | 321,386.60 | 7.21 | 8.38 | 9.59 | 11.40 | 50.08 | 49.85 | 11.28 | 11.39 | 0.7244 | 43.06 | 0.5419 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Teleflex Inc | 3.01bn | 264.76m | 11.38bn | 14.50k | 43.17 | 2.50 | 21.85 | 3.78 | 5.59 | 5.57 | 63.54 | 96.76 | 0.4196 | 2.09 | 6.85 | 207,437.10 | 3.69 | 5.86 | 4.00 | 6.42 | 55.86 | 54.43 | 8.80 | 14.62 | 1.44 | 7.14 | 0.2737 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Revvity Inc | 2.71bn | 197.34m | 15.37bn | 11.50k | 78.01 | 1.95 | 24.53 | 5.67 | 1.60 | 1.37 | 21.90 | 63.80 | 0.1959 | 2.89 | 4.42 | 235,499.60 | 1.43 | 4.76 | 1.59 | 5.39 | 55.26 | 57.19 | 7.29 | 15.34 | 1.98 | 6.89 | 0.3299 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Insulet Corp | 1.87bn | 395.30m | 16.55bn | 3.00k | 43.62 | 16.58 | 35.16 | 8.84 | 5.41 | 5.41 | 24.53 | 14.24 | 0.711 | 1.38 | 6.25 | 624,233.30 | 15.01 | 2.71 | 18.15 | 3.14 | 69.00 | 65.81 | 21.11 | 4.28 | 2.71 | 87.97 | 0.5833 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Avantor Inc | 6.83bn | 360.20m | 18.40bn | 14.50k | 51.10 | 3.38 | 24.17 | 2.70 | 0.5295 | 0.5295 | 10.03 | 8.00 | 0.530 | 5.37 | 5.82 | 470,731.00 | 2.80 | 2.97 | 3.17 | 3.35 | 33.71 | 33.44 | 5.28 | 5.06 | 1.05 | 3.07 | 0.4848 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Align Technology, Inc. | 3.94bn | 447.03m | 18.90bn | 21.61k | 42.91 | 5.03 | 32.20 | 4.79 | 5.90 | 5.90 | 52.03 | 50.31 | 0.641 | 4.16 | 4.09 | 182,455.40 | 7.27 | 16.34 | 10.96 | 24.14 | 69.82 | 71.72 | 11.34 | 23.16 | 1.06 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Hologic Inc | 3.99bn | 701.50m | 18.98bn | 6.99k | 27.89 | 3.83 | 18.77 | 4.76 | 2.93 | 2.93 | 16.59 | 21.33 | 0.4375 | 2.64 | 6.06 | 570,472.10 | 7.70 | 11.40 | 8.64 | 13.38 | 55.41 | 60.29 | 17.59 | 20.95 | 3.32 | 709.77 | 0.3408 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Waters Corp | 2.88bn | 595.69m | 19.79bn | 7.90k | 33.21 | 14.01 | 25.13 | 6.88 | 10.04 | 10.04 | 48.46 | 23.79 | 0.6394 | 2.19 | 4.41 | 364,118.20 | 13.24 | 19.77 | 16.04 | 25.29 | 59.68 | 58.45 | 20.71 | 23.38 | 1.42 | 8.74 | 0.5869 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Baxter International Inc | 15.00bn | -157.00m | 20.09bn | 60.00k | -- | 2.63 | 18.10 | 1.34 | -0.3066 | 4.87 | 29.48 | 14.98 | 0.5534 | 3.24 | 5.73 | 249,950.00 | -0.5462 | 0.1942 | -0.7019 | 0.2333 | 36.48 | 38.20 | -0.9869 | 0.3674 | 0.9147 | 4.25 | 0.626 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Illumina Inc | 4.43bn | -3.04bn | 20.86bn | 10.59k | -- | 14.50 | -- | 4.71 | -19.18 | -19.18 | 27.94 | 9.03 | 0.4961 | 2.86 | 6.26 | 418,224.80 | -34.09 | -6.20 | -45.61 | -7.28 | 62.00 | 66.39 | -68.71 | -15.48 | 0.8596 | 14.07 | 0.6087 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| Zimmer Biomet Holdings Inc | 7.52bn | 997.10m | 21.64bn | 18.00k | 22.15 | 1.71 | 11.03 | 2.88 | 4.80 | 4.80 | 36.22 | 62.18 | 0.3515 | 0.9141 | 5.40 | 418,050.00 | 4.66 | 2.21 | 5.40 | 2.52 | 71.78 | 71.25 | 13.27 | 7.28 | 0.629 | 7.51 | 0.314 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Cooper Companies Inc | 3.80bn | 359.30m | 22.01bn | 15.00k | 61.55 | 2.78 | 29.90 | 5.79 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| West Pharmaceutical Services Inc. | 2.88bn | 524.90m | 22.43bn | 10.60k | 43.93 | 8.71 | 34.23 | 7.80 | 7.04 | 7.04 | 38.62 | 35.49 | 0.8037 | 4.26 | 5.68 | 271,405.70 | 14.22 | 15.61 | 16.93 | 18.65 | 35.69 | 38.06 | 17.70 | 18.47 | 1.68 | -- | 0.0751 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Steris PLC | 5.13bn | 567.70m | 23.51bn | 18.18k | 41.66 | 3.71 | 21.19 | 4.58 | 5.72 | 4.03 | 51.73 | 64.32 | 0.4914 | 3.98 | 5.77 | 282,395.10 | 5.45 | 5.19 | 5.95 | 5.68 | 43.19 | 43.64 | 11.09 | 10.97 | 1.49 | 7.03 | 0.2666 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
Data as of Sep 19 2024. Currency figures normalised to Avantor Inc's reporting currency: US Dollar USD
48.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Investment Management, Inc.as of 30 Jun 2024 | 69.67m | 10.25% |
| Dodge & Coxas of 31 Jul 2024 | 68.65m | 10.10% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 62.66m | 9.22% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 25.15m | 3.70% |
| Canada Pension Plan Investment Boardas of 30 Jun 2024 | 22.93m | 3.37% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 30 Jun 2024 | 22.28m | 3.28% |
| Boston Partners Global Investors, Inc.as of 30 Jun 2024 | 19.23m | 2.83% |
| Janus Henderson Investors US LLCas of 30 Jun 2024 | 14.90m | 2.19% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 14.16m | 2.08% |
| Geode Capital Management LLCas of 30 Jun 2024 | 10.41m | 1.53% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
